Related Experiment Videos
Genomic aberrations in renal cell carcinomas detected by restriction landmark genomic scanning
1Second Department of Pathology, Nara Medical University, Japan.
Abstract:
In order to reveal and characterise genetic events occurring in renal tumorigenesis, samples of sporadic renal cell carcinomas (RCCs) were examined using restriction landmark genomic scanning (RLGS), an electrophoretic separation technique which detects gene amplification and deletion. We were able to find two fragments frequently amplified and 10 others commonly showing reduced signal intensity within the 16 tumour samples analysed. These altered spots were located on chromosomes 2, 3, 9-12, 16, 17 and 18 according to chromosomal assigned RLGS. A subset of reduced fragments appeared to be correlated to tumour type and were located within a new chromosomal region, suggesting genetic specificity within the process of renal carcinogenesis.
Insights
Researchers identified genetic alterations in sporadic renal cell carcinomas (RCCs) using restriction landmark genomic scanning (RLGS). They found gene amplifications and deletions, with some changes potentially linked to specific tumor types, indicating genetic specificity in kidney cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) is a significant health concern.
- Understanding the genetic basis of RCC is crucial for diagnosis and treatment.
- Sporadic RCC lacks a clear inherited genetic predisposition.
Purpose of the Study:
- To identify and characterize genetic events in sporadic renal cell carcinoma (RCC) tumorigenesis.
- To investigate gene amplification and deletion patterns in RCC samples.
Main Methods:
- Utilized Restriction Landmark Genomic Scanning (RLGS), an electrophoretic technique.
- Analyzed 16 samples of sporadic renal cell carcinomas.
- Mapped altered genomic regions to specific chromosomes.
Main Results:
- Identified two frequently amplified DNA fragments.
- Detected reduced signal intensity in 10 other genomic regions.
- Located these alterations on chromosomes 2, 3, 9-12, 16, 17, and 18.
- Observed a correlation between a subset of reduced fragments and tumor type, suggesting novel chromosomal regions involved in renal carcinogenesis.
Conclusions:
- Restriction Landmark Genomic Scanning (RLGS) is effective in detecting genetic alterations in RCC.
- Specific gene amplifications and deletions are associated with sporadic RCC.
- Genetic alterations, particularly those in novel regions, may indicate tumor-specific pathways in renal carcinogenesis.